Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
  1. 4 Open-market buy 10% owner bought 2,500,000 shares at $10.00 ($25,000,000)
  2. 4 Open-market buy 10% owner bought 2,500,000 shares at $10.00 ($25,000,000)
  3. 4 Conversion 10% owner acquired 62,540 shares (conversion)
  4. 4 Open-market buy Director bought 11,250 shares at $10.00 ($112,500)
  5. 4 Open-market buy 10% owner bought 481,000 shares at $10.00 ($4,810,000)
  6. 4 Open-market buy 10% owner bought 100,000 shares at $10.00 ($1,000,000)
  7. 4 Conversion 10% owner acquired 99,046 shares (conversion)
  8. 4 Open-market buy Director bought 2,500 shares at $10.00 ($25,000)
  9. 4 Open-market buy GOOD JENNIFER L bought 11,250 shares at $10.00 ($112,500)
  10. 4 Open-market buy 10% owner bought 112,000 shares at $10.00 ($1,120,000)
  11. 4 Open-market buy Director bought 375,000 shares at $10.00 ($3,750,000)
  12. 4 Open-market buy 10% owner bought 100,000 shares at $10.00 ($1,000,000)
  13. 4 Open-market buy Director bought 5,000 shares at $10.00 ($50,000)
  14. 4 Open-market buy 10% owner bought 375,000 shares at $10.00 ($3,750,000)
  15. 4 Conversion 10% owner acquired 62,540 shares (conversion)
  16. 4 Conversion Chief Medical Officer acquired 17,118 shares (conversion)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 13 · 257 filings